Precise reporting of traditional Chinese medicine interventions in randomized controlled trials

Zhaoxiang BIAN*, David Moher, You Ping Li, Tai Xiang Wu, Simon Dagenais, Chung Wah Cheng, Jing Li, Ting Qian Li

*Corresponding author for this work

Research output: Contribution to journalEditorial

11 Citations (Scopus)


Traditional Chinese medicine (TCM) intervention should be concisely and precisely reported in randomized controlled trials (RCTs). Based on State Food and Drug Administration's categories, we recommend reporting the interventions as follows: (1) Single Chinese herbal medicine-based/ formula-based/extraction-based intervention includes 1) Name, dosage format and registration; 2)The composition and quality of intervention; 3) Pharmaceutical processing and quality control; 4) Stability of final product and quality control; 5) Function and safety description; 6) Dosage and treatment course; 7) Control group. (2) Active compound-based TCM drug intervention includes 1) Name of active compound(s); 2) Original source of active compound(s); 3) The brief process obtaining active compound(s); 4) Percentage of active compound(s) in final product; 5) Added materials and its quality and quantity control. Besides, the detailed information of intervention can be published as an online supplement in web site.

Original languageEnglish
Pages (from-to)661-667
Number of pages7
JournalJournal of integrative medicine
Issue number7
Publication statusPublished - 15 Jul 2008

Scopus Subject Areas

  • Complementary and alternative medicine

User-Defined Keywords

  • Chinese herbal drugs
  • Clinical research
  • Evidence-based medicine
  • Randomized controlled trials
  • Traditional Chinese medicine


Dive into the research topics of 'Precise reporting of traditional Chinese medicine interventions in randomized controlled trials'. Together they form a unique fingerprint.

Cite this